The Drug Controller General of India (DCGI) has given nod to Bharat Biotech to conduct phase-3 trials for its COVID-19 intra-nasal vaccine (BBV154), reports said on Friday.

https://nenow.in/health/dcgi-gives-nod-to-bharat-biotech-for-intra-nasal-vaccine-phase-3-trials.html